Video Experimental Relacionado
Updated: Feb 24, 2026
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
10.2K
Desarrollo de la Extensión RxNorm: Un Paso Hacia la Armonización Global de Datos de Medicamentos en la Investigación
Anna Ostropolets1,2, Aleh Zhuk3, Eduard Korchmar3
1Columbia University, New York NY, United States.
AMIA ... Annual Symposium proceedings. AMIA Symposium
|February 23, 2026
Resumen
La Extensión RxNorm (RxE) armoniza datos internacionales de medicamentos utilizando un enfoque de mapeo basado en atributos. Este vocabulario de medicamentos estandarizado mejora la investigación global sobre seguridad de medicamentos al mejorar la coherencia entre las bases de datos.
Área de la Ciencia:
- Farmacología e Informática de Medicamentos
- Lingüística Computacional
- Estandarización de Datos de Salud
Sus antecedentes:
- Los datos internacionales de medicamentos existen en vocabularios dispares y no estandarizados.
- La armonización de la información sobre medicamentos es crucial para la investigación global sobre seguridad y efectividad de medicamentos.
- Los estándares existentes como RxNorm (EE. UU.) proporcionan una base para la normalización de datos.
Objetivo del estudio:
- Presentar la Extensión RxNorm (RxE), un novedoso sistema de vocabulario de medicamentos estandarizado.
- Armonizar datos de medicamentos de múltiples repositorios internacionales de medicamentos.
- Mejorar la investigación global sobre seguridad y efectividad de medicamentos a través de representaciones de medicamentos estandarizadas.
Principales métodos:
- Desarrollo de un enfoque de mapeo basado en atributos para la integración de datos.
- Integración de 12 vocabularios internacionales de medicamentos en el sistema RxE.
- Estandarización de vocabularios de medicamentos dispares a una estructura que sigue el estándar de referencia RxNorm de EE. UU.
Principales resultados:
- Se observaron patrones similares de uso de formas de dosificación e ingredientes entre los vocabularios integrados.
- Se identificó un número significativamente mayor de nombres de marca a nivel mundial en comparación con las variaciones de ingredientes o formas de dosificación.
- Se destacaron desafíos en la calidad de RxE, incluidas discrepancias en los nombres de marca, formas de dosificación mal estructuradas y dosis defectuosas.
Conclusiones:
- La Extensión RxNorm (RxE) proporciona una herramienta valiosa para armonizar datos internacionales de medicamentos.
- El enfoque de mapeo basado en atributos mejora la coherencia y reduce el procesamiento manual de datos.
- El trabajo futuro debe centrarse en expandir la cobertura de RxE, automatizar el mapeo y fomentar la colaboración internacional para optimizar la seguridad global de los medicamentos.
Palabras clave:
Extensión RxNormarmonización de datosvocabulario de medicamentosinvestigación de seguridad de medicamentosinvestigación de efectividad de medicamentosdatos farmacéuticos internacionalesestandarización de datosmapeo basado en atributosMás Videos Relacionados
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
5.8K
08:27Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
4.9K
Videos de Conceptos Relacionados
01:24Dosage Regimen: Individualization
230
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
230
01:19Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
271
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
271
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
225
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
225
01:12Analysis of Population Pharmacokinetic Data
843
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
843